3et1
Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acidStructure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid
Template:ABSTRACT PUBMED 19116277
About this StructureAbout this Structure
3ET1 is a 4 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K, Bollag G, Ibrahim PN, Tobin JF. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. Epub 2008 Dec 30. PMID:19116277
Page seeded by OCA on Wed Feb 18 09:02:27 2009
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Histone acetyltransferase
- Homo sapiens
- Wang, W.
- Zhang, K Y.J.
- Activator
- Acyltransferase
- Adiponectin
- Alternative splicing
- Chromosomal rearrangement
- Diabetes
- Dna-binding
- Drug discovery
- Fragment-based drug discovery
- Metabolic disease
- Metal-binding
- Nucleus
- Phosphoprotein
- Polymorphism
- Ppar
- Ppara
- Pparalpha
- Proto-oncogene
- Receptor
- Scaffold-based drug discovery
- Transcription
- Transcription regulation
- Transcription/transferase complex
- Transferase
- Ubl conjugation
- Zinc
- Zinc-finger